logo

UK Pharmaceutical Logistics Market Size (2024 - 2029)

The United Kingdom Pharmaceutical Logistics Market is experiencing growth driven by the increasing demand for temperature-controlled transportation and warehousing, essential for maintaining the quality of sensitive pharmaceutical products such as biologics and vaccines. The market's expansion is further supported by the UK government's initiatives to enhance cold chain logistics, addressing the needs of the pharmaceutical sector, which has been significantly impacted by transportation delays due to Covid-19. This growth in the pharmaceutical sector is expected to positively influence the overall logistics market size in the UK, as companies adapt their strategies to ensure efficient delivery and storage of temperature-sensitive products.

Home Market Analysis Logistics Research Cold Chain Logistics Research Healthcare Cold Chain Research Pharma Cold Chain Research UK Pharmaceutical Logistics Market Market Size

Market Size of UK Pharmaceutical Logistics Industry

UK Pharmaceutical Logistics Market Summary
Study Period 2024 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 10.83 Billion
Market Size (2029) USD 13.25 Billion
CAGR (2024 - 2029) 4.12 %
Market Concentration Low

Major Players

UK Pharmaceutical Logistics Market Major Players

*Disclaimer: Major Players sorted in no particular order

UK Pharmaceutical Logistics Market Analysis

The UK Pharmaceutical Logistics Market size is estimated at USD 10.83 billion in 2024, and is expected to reach USD 13.25 billion by 2029, at a CAGR of 4.12% during the forecast period (2024-2029).

  • The pharmaceutical sector in the United Kingdom plays a pivotal role. Key trends shaping this sector include an uptick in outsourced logistics operations, technological advancements in cold chain management, and a growing demand for biologics and temperature-sensitive medications, notably vaccines and monoclonal antibodies.
  • The UK's Medicine and Healthcare products Regulatory Agency (MHRA) oversees the safety, quality, and efficacy of medicines, medical devices, and other healthcare products. Manufacturers must comply with MHRA regulations to legally introduce their products into the UK healthcare system. The agency also holds the authority to intervene in the marketing and supply of devices that fail to meet established standards.
  • For instance, Mawdsleys, an MHRA-approved storage facility, provides a range of services including refrigerated storage, controlled drug storage, cytotoxic substance storage, and active substance storage. Additionally, they offer dedicated warehouses that cater to both medical device and OTC storage needs.
  • In the UK, the pharmaceutical logistics market is witnessing a growing demand for efficient and cost-effective solutions, especially when it comes to handling temperature-sensitive products.
  • Pharmaceutical producers in U.K. are increasingly prioritizing product sensitivity and quality. Factors such as the advancement of sophisticated biological medicines and the distribution of hormone treatments, vaccinations, and intricate proteins, all necessitating cold chain enhancements, have heightened the demand for temperature-controlled transportation and warehousing.
  • Moreover, the surging demand for temperature-controlled logistics in pharmaceuticals and medical devices is propelling the growth of the healthcare logistics market. In the UK, the cold chain logistics market is witnessing expansion, driven by the increasing need for efficient services that safeguard the quality of pharmaceutical products.

UK Pharmaceutical Logistics Industry Segmentation

Pharmaceutical logistics involves manufacturing, processing, and shipping materials and resources. Pharmaceutical Logistics companies also undertake activities related to handling finished products for customers.

Transporting healthcare products requires sophisticated logistics to ensure the integrity of pharmaceutical shipments. This involves specialized equipment, dedicated storage facilities, standardized handling procedures, and strong collaboration among cold chain partners. Logistics companies play a crucial role in the operations of pharmaceutical firms.

The United Kingdom Pharmaceutical Logistics market is segmented by product (generic drugs, branded drugs), by mode of operation (cold chain transport, non-cold chain transport), by application (bio pharma, chemical pharma), by mode of transport (air, rail, road, and sea) The report offers market size and forecast for United Kingdom Pharmaceutical Logistics Market in value (USD) for all the above segments.

By Product
Generic Drugs
Branded Drugs
By Operation
Cold Chain Transport
Non-cold Chain Transport
By Application
Biopharma
Chemical Pharma
By Transportation
Airways
Railways
Roadways
Seaways
Need A Different Region Or Segment?
Customize Now

UK Pharmaceutical Logistics Market Size Summary

The United Kingdom pharmaceutical logistics market is a vital component of the country's healthcare infrastructure, playing a crucial role in the distribution and storage of pharmaceutical products. The market is characterized by its focus on temperature-sensitive logistics, driven by the need to maintain the integrity of biologics, vaccines, and other medical products that require precise temperature control. The demand for cold chain logistics is on the rise, fueled by the development of sophisticated biological medicines and the ongoing distribution of COVID-19 vaccinations. This segment is expected to experience significant growth during the forecast period, supported by government initiatives and the increasing adoption of advanced supply chain technologies such as telematics and GPS integration. The market is highly fragmented, with key players like Vision Logistics, Alloga, and Alliance Healthcare continuously engaging in strategic mergers and acquisitions to enhance their capabilities and expand their reach.

The pharmaceutical logistics sector in the UK is also witnessing a shift towards direct-to-patient delivery models, driven by the growth of the on-demand healthcare sector and advancements in technology. This trend is facilitated by the rise of online pharmacies, point-of-care diagnostics, and remote monitoring services, which offer greater accessibility and convenience to patients. Companies are increasingly investing in B2B integration platforms with electronic data interchange capabilities to streamline their operations and ensure timely delivery of medications. The market's growth is further supported by strategic acquisitions, such as UPS's acquisition of Bomi Group, which enhances its temperature-controlled logistics capabilities across Europe and Latin America. These developments underscore the importance of efficient and reliable logistics solutions in the pharmaceutical industry, as companies strive to meet the evolving demands of the healthcare market.

Explore More

UK Pharmaceutical Logistics Market Size - Table of Contents

  1. 1. MARKET INSIGHTS AND DYNAMICS

    1. 1.1 Current Market Scenario

    2. 1.2 Market Drivers

      1. 1.2.1 Increased Demand for Pharmaceuticals

      2. 1.2.2 Government Support and Investments

    3. 1.3 Market Restraints

      1. 1.3.1 Regulatory Challenges

      2. 1.3.2 Supply Chain Disruptions

    4. 1.4 Market Oppurtunities

      1. 1.4.1 Expansion into Emerging Markets

      2. 1.4.2 Focus on Personalized Medicine

    5. 1.5 Industry Attractiveness - Porters Five Force's Analysis

      1. 1.5.1 Threat of New Entrants

      2. 1.5.2 Bargaining Power of Buyers/Consumers

      3. 1.5.3 Bargaining Power of Suppliers

      4. 1.5.4 Threat of Substitute Products

      5. 1.5.5 Intensity of Competitive Rivalry

    6. 1.6 Insights Into The 3PL Market in United Kingdom

    7. 1.7 Value Chain / Supply Chain Analysis

    8. 1.8 Impact of Geopolitics and Pandemic on the Market

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Generic Drugs

      2. 2.1.2 Branded Drugs

    2. 2.2 By Operation

      1. 2.2.1 Cold Chain Transport

      2. 2.2.2 Non-cold Chain Transport

    3. 2.3 By Application

      1. 2.3.1 Biopharma

      2. 2.3.2 Chemical Pharma

    4. 2.4 By Transportation

      1. 2.4.1 Airways

      2. 2.4.2 Railways

      3. 2.4.3 Roadways

      4. 2.4.4 Seaways

UK Pharmaceutical Logistics Market Size FAQs

The UK Pharmaceutical Logistics Market size is expected to reach USD 10.83 billion in 2024 and grow at a CAGR of 4.12% to reach USD 13.25 billion by 2029.

In 2024, the UK Pharmaceutical Logistics Market size is expected to reach USD 10.83 billion.

UK Pharmaceutical Logistics Market Report Snapshots

United Kingdom Pharmaceutical Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)